The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality

BACKGROUND: Impaired T cell immune function exists in end-stage renal disease (ESRD) patients. Dialysis treatment may lead to changes in T cell subsets. In the present study, we aimed to identify alterations of T cell phenotypes in ESRD patients, especially in those receiving peritoneal dialysis (PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiaoyan, Jiao, Rongyi, Chen, Xuesen, Cao, Jianzhou, Zou, Jun, Ji, Xiaoqiang, Ding, Xiaofang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683494/
https://www.ncbi.nlm.nih.gov/pubmed/31383007
http://dx.doi.org/10.1186/s12882-019-1475-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683494/
https://www.ncbi.nlm.nih.gov/pubmed/31383007
http://dx.doi.org/10.1186/s12882-019-1475-y

Ejemplares similares